US Stock MarketDetailed Quotes

Fortress Biotech (FBIO)

Watchlist
  • 2.390
  • -0.010-0.42%
Close May 8 16:00 ET
  • 2.491
  • +0.101+4.21%
Post 20:01 ET
79.39MMarket Cap-34.14P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fortress Biotech (FBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
9.69%63.26M
6.34%16.08M
20.52%17.63M
10.18%16.41M
0.84%13.14M
-31.76%57.68M
-24.20%15.12M
-57.90%14.63M
-14.32%14.9M
4.84%13.03M
Operating revenue
8.05%61.24M
13.78%16.07M
16.38%17.03M
0.76%15.01M
0.84%13.14M
-12.80%56.68M
-29.21%14.12M
-5.57%14.63M
-13.27%14.9M
5.24%13.03M
Cost of revenue
0.22%20.92M
16.24%5.44M
28.72%5.76M
-13.76%4.94M
-20.19%4.79M
-8.80%20.88M
108.19%4.68M
-30.46%4.47M
-26.26%5.73M
-6.93%6M
Gross profit
15.06%42.34M
1.91%10.64M
16.91%11.88M
25.14%11.47M
18.80%8.35M
-40.29%36.8M
-41.01%10.44M
-64.14%10.16M
-4.68%9.17M
17.53%7.03M
Operating expense
-23.97%112.56M
-59.17%15.43M
-42.06%18.69M
39.75%47.95M
-29.66%30.67M
-26.28%148.04M
1.27%37.79M
-23.35%32.25M
-39.36%34.31M
-32.77%43.59M
Selling and administrative expenses
9.88%96.4M
-45.17%14.73M
-20.82%17.42M
86.13%38.76M
43.04%25.66M
-3.57%87.73M
37.98%26.86M
1.20%21.99M
-14.80%20.82M
-29.20%17.94M
Research and development costs
-79.08%11.9M
-103.69%-367K
-97.80%208K
-35.87%8.13M
-84.15%3.94M
-46.37%56.88M
-29.38%9.94M
-53.58%9.45M
-60.58%12.67M
-37.13%24.84M
Depreciation amortization depletion
24.36%4.26M
8.56%1.07M
30.71%1.06M
30.71%1.06M
30.84%1.07M
-9.11%3.42M
--981K
--814K
--814K
--814K
-Depreciation and amortization
24.36%4.26M
8.56%1.07M
30.71%1.06M
30.71%1.06M
30.84%1.07M
-9.11%3.42M
--981K
--814K
--814K
--814K
Operating profit
36.87%-70.22M
82.49%-4.79M
69.17%-6.81M
-45.09%-36.47M
38.97%-22.32M
20.09%-111.24M
-39.42%-27.35M
-60.60%-22.1M
46.47%-25.14M
37.88%-36.57M
Net non-operating interest income expense
29.72%-7.62M
32.11%-1.4M
64.31%-2.01M
-36.60%-1.9M
-30.86%-2.32M
11.92%-10.84M
-52.96%-2.07M
-182.84%-5.62M
75.69%-1.39M
45.74%-1.77M
Non-operating interest income
-7.38%2.49M
21.10%637K
24.96%736K
-15.26%622K
-41.18%490K
-10.66%2.68M
-25.60%526K
7.68%589K
2.66%734K
-19.59%833K
Non-operating interest expense
-24.84%8.71M
-70.88%1.71M
8.01%2.42M
39.10%2.07M
25.94%2.51M
-2.74%11.59M
287.33%5.87M
19.13%2.24M
-71.34%1.49M
-39.97%1.99M
Total other finance cost
-27.95%1.4M
110.14%332K
-91.77%327K
-29.64%444K
-51.56%295K
-42.97%1.94M
-701.84%-3.27M
504.72%3.97M
-48.41%631K
-37.60%609K
Other net income (expense)
2,775.21%44.31M
-100.58%-20K
1,521.10%17.67M
1,263.04%26.72M
91.42%-59K
172.62%1.54M
144.96%3.43M
-78.88%1.09M
65.35%-2.3M
-109.85%-688K
Gain on sale of security
37.62%-398K
101.67%1K
-110.53%-2K
-600.00%-350K
92.95%-47K
-114.42%-638K
99.05%-60K
-99.58%19K
113.67%70K
-109.99%-667K
Special income (charges)
3,050.64%27.13M
--0
--0
1,124.05%27.13M
----
127.39%861K
--3.51M
--0
59.32%-2.65M
----
-Less:Impairment of capital assets
--0
--0
--0
--0
----
17.47%3.69M
--1.04M
--0
-15.72%2.65M
----
-Less:Other special charges
----
----
----
----
----
---4.55M
----
----
----
----
-Write off
----
----
--0
--0
----
17.47%3.69M
--1.04M
--0
-15.72%2.65M
----
-Gain on sale of business
--27.13M
--0
--0
--27.13M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
1,233.69%17.58M
-31.25%-21K
1,550.05%17.67M
-121.99%-62K
42.86%-12K
138.73%1.32M
98.82%-16K
72.74%1.07M
-28.61%282K
-106.91%-21K
Income before tax
72.18%-33.54M
76.08%-6.21M
133.25%8.85M
59.57%-11.65M
36.73%-24.69M
21.54%-120.54M
9.18%-25.98M
-151.58%-26.63M
51.39%-28.82M
29.24%-39.02M
Income tax
-298.72%-620K
-342.86%-816K
-62.32%26K
-40.12%312K
-11.35%336K
-51.06%69K
Net income
72.76%-32.92M
79.49%-5.4M
133.07%8.83M
59.57%-11.65M
36.73%-24.69M
21.60%-120.86M
9.21%-26.32M
-148.92%-26.69M
51.39%-28.82M
29.24%-39.02M
Net income continuous Operations
72.76%-32.92M
79.49%-5.4M
133.07%8.83M
59.57%-11.65M
36.73%-24.69M
21.60%-120.86M
9.21%-26.32M
-148.92%-26.69M
51.39%-28.82M
29.24%-39.02M
Minority interest income
46.93%-39.73M
92.53%-1.46M
121.53%2.98M
-51.82%-27.14M
40.24%-14.11M
19.95%-74.86M
0.79%-19.55M
-143.48%-13.83M
48.22%-17.88M
29.76%-23.61M
Net income attributable to the parent company
114.82%6.82M
41.80%-3.94M
145.47%5.85M
241.45%15.49M
31.35%-10.58M
24.14%-46M
27.09%-6.77M
-155.04%-12.87M
55.81%-10.95M
28.42%-15.42M
Preferred stock dividends
-12.09%8.7M
-21.68%2.26M
0.05%2.17M
-10.87%2.13M
-12.74%2.13M
23.17%9.89M
43.77%2.89M
8.22%2.17M
19.55%2.39M
2.44M
Other preferred stock dividends
300.00%400K
-300K
Net income attributable to common stockholders
96.63%-1.88M
35.79%-6.2M
124.43%3.68M
200.12%13.36M
28.80%-12.72M
18.61%-55.89M
14.49%-9.65M
-113.24%-15.04M
50.44%-13.34M
24.15%-17.86M
Basic earnings per share
97.40%-0.07
11.54%-0.23
117.11%0.13
168.49%0.5
53.85%-0.48
68.24%-2.69
50.94%-0.26
19.15%-0.76
80.00%-0.73
70.03%-1.04
Diluted earnings per share
97.40%-0.07
11.54%-0.23
114.47%0.11
161.64%0.45
53.85%-0.48
68.24%-2.69
50.94%-0.26
19.15%-0.76
80.00%-0.73
70.03%-1.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 9.69%63.26M6.34%16.08M20.52%17.63M10.18%16.41M0.84%13.14M-31.76%57.68M-24.20%15.12M-57.90%14.63M-14.32%14.9M4.84%13.03M
Operating revenue 8.05%61.24M13.78%16.07M16.38%17.03M0.76%15.01M0.84%13.14M-12.80%56.68M-29.21%14.12M-5.57%14.63M-13.27%14.9M5.24%13.03M
Cost of revenue 0.22%20.92M16.24%5.44M28.72%5.76M-13.76%4.94M-20.19%4.79M-8.80%20.88M108.19%4.68M-30.46%4.47M-26.26%5.73M-6.93%6M
Gross profit 15.06%42.34M1.91%10.64M16.91%11.88M25.14%11.47M18.80%8.35M-40.29%36.8M-41.01%10.44M-64.14%10.16M-4.68%9.17M17.53%7.03M
Operating expense -23.97%112.56M-59.17%15.43M-42.06%18.69M39.75%47.95M-29.66%30.67M-26.28%148.04M1.27%37.79M-23.35%32.25M-39.36%34.31M-32.77%43.59M
Selling and administrative expenses 9.88%96.4M-45.17%14.73M-20.82%17.42M86.13%38.76M43.04%25.66M-3.57%87.73M37.98%26.86M1.20%21.99M-14.80%20.82M-29.20%17.94M
Research and development costs -79.08%11.9M-103.69%-367K-97.80%208K-35.87%8.13M-84.15%3.94M-46.37%56.88M-29.38%9.94M-53.58%9.45M-60.58%12.67M-37.13%24.84M
Depreciation amortization depletion 24.36%4.26M8.56%1.07M30.71%1.06M30.71%1.06M30.84%1.07M-9.11%3.42M--981K--814K--814K--814K
-Depreciation and amortization 24.36%4.26M8.56%1.07M30.71%1.06M30.71%1.06M30.84%1.07M-9.11%3.42M--981K--814K--814K--814K
Operating profit 36.87%-70.22M82.49%-4.79M69.17%-6.81M-45.09%-36.47M38.97%-22.32M20.09%-111.24M-39.42%-27.35M-60.60%-22.1M46.47%-25.14M37.88%-36.57M
Net non-operating interest income expense 29.72%-7.62M32.11%-1.4M64.31%-2.01M-36.60%-1.9M-30.86%-2.32M11.92%-10.84M-52.96%-2.07M-182.84%-5.62M75.69%-1.39M45.74%-1.77M
Non-operating interest income -7.38%2.49M21.10%637K24.96%736K-15.26%622K-41.18%490K-10.66%2.68M-25.60%526K7.68%589K2.66%734K-19.59%833K
Non-operating interest expense -24.84%8.71M-70.88%1.71M8.01%2.42M39.10%2.07M25.94%2.51M-2.74%11.59M287.33%5.87M19.13%2.24M-71.34%1.49M-39.97%1.99M
Total other finance cost -27.95%1.4M110.14%332K-91.77%327K-29.64%444K-51.56%295K-42.97%1.94M-701.84%-3.27M504.72%3.97M-48.41%631K-37.60%609K
Other net income (expense) 2,775.21%44.31M-100.58%-20K1,521.10%17.67M1,263.04%26.72M91.42%-59K172.62%1.54M144.96%3.43M-78.88%1.09M65.35%-2.3M-109.85%-688K
Gain on sale of security 37.62%-398K101.67%1K-110.53%-2K-600.00%-350K92.95%-47K-114.42%-638K99.05%-60K-99.58%19K113.67%70K-109.99%-667K
Special income (charges) 3,050.64%27.13M--0--01,124.05%27.13M----127.39%861K--3.51M--059.32%-2.65M----
-Less:Impairment of capital assets --0--0--0--0----17.47%3.69M--1.04M--0-15.72%2.65M----
-Less:Other special charges -----------------------4.55M----------------
-Write off ----------0--0----17.47%3.69M--1.04M--0-15.72%2.65M----
-Gain on sale of business --27.13M--0--0--27.13M------0--0--0--0----
Other non- operating income (expenses) 1,233.69%17.58M-31.25%-21K1,550.05%17.67M-121.99%-62K42.86%-12K138.73%1.32M98.82%-16K72.74%1.07M-28.61%282K-106.91%-21K
Income before tax 72.18%-33.54M76.08%-6.21M133.25%8.85M59.57%-11.65M36.73%-24.69M21.54%-120.54M9.18%-25.98M-151.58%-26.63M51.39%-28.82M29.24%-39.02M
Income tax -298.72%-620K-342.86%-816K-62.32%26K-40.12%312K-11.35%336K-51.06%69K
Net income 72.76%-32.92M79.49%-5.4M133.07%8.83M59.57%-11.65M36.73%-24.69M21.60%-120.86M9.21%-26.32M-148.92%-26.69M51.39%-28.82M29.24%-39.02M
Net income continuous Operations 72.76%-32.92M79.49%-5.4M133.07%8.83M59.57%-11.65M36.73%-24.69M21.60%-120.86M9.21%-26.32M-148.92%-26.69M51.39%-28.82M29.24%-39.02M
Minority interest income 46.93%-39.73M92.53%-1.46M121.53%2.98M-51.82%-27.14M40.24%-14.11M19.95%-74.86M0.79%-19.55M-143.48%-13.83M48.22%-17.88M29.76%-23.61M
Net income attributable to the parent company 114.82%6.82M41.80%-3.94M145.47%5.85M241.45%15.49M31.35%-10.58M24.14%-46M27.09%-6.77M-155.04%-12.87M55.81%-10.95M28.42%-15.42M
Preferred stock dividends -12.09%8.7M-21.68%2.26M0.05%2.17M-10.87%2.13M-12.74%2.13M23.17%9.89M43.77%2.89M8.22%2.17M19.55%2.39M2.44M
Other preferred stock dividends 300.00%400K-300K
Net income attributable to common stockholders 96.63%-1.88M35.79%-6.2M124.43%3.68M200.12%13.36M28.80%-12.72M18.61%-55.89M14.49%-9.65M-113.24%-15.04M50.44%-13.34M24.15%-17.86M
Basic earnings per share 97.40%-0.0711.54%-0.23117.11%0.13168.49%0.553.85%-0.4868.24%-2.6950.94%-0.2619.15%-0.7680.00%-0.7370.03%-1.04
Diluted earnings per share 97.40%-0.0711.54%-0.23114.47%0.11161.64%0.4553.85%-0.4868.24%-2.6950.94%-0.2619.15%-0.7680.00%-0.7370.03%-1.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -